Medtronic MDT
NYSE MDT
$103.05 +2.06 (+2.04%)
As of: Nov 13, 2026 · 12:04 PM EST

Medtronic (MDT) Gains (Losses) on Sale of Assets & Investments (2016 - 2018)

Updated

Medtronic's Non Operating Investment Income was $697 million in FY2018 (year ended Apr 27, 2018).

Analysis

Medtronic (MDT) Gains (Losses) on Sale of Assets & Investments (2016 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn -
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn -
3 Danaher 161.92 Bn 141.57 Bn 3.84 Bn -
4 Intuitive Surgical 155.43 Bn 135.72 Bn 2.08 Bn -
5 Medtronic 131.93 Bn 97.45 Bn 6.34 Bn -
6 Stryker 119.74 Bn 105.93 Bn 4.25 Bn -
7 Boston Scientific 64.30 Bn 59.73 Bn 3.43 Bn -
8 Edwards Lifesciences 61.65 Bn 44.86 Bn 1.35 Bn -
9 Agilent Technologies 48.79 Bn 41.68 Bn 1.04 Bn -
10 GE HealthCare Technologies 37.34 Bn 25.57 Bn 2.22 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -697.00 Mn
Oct 27, 2017 697.00 Mn
Dec 31, 2016 70.00 Mn
API Access

Medtronic Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=MDT&period=max&api_key=YOUR_API_KEY